Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SAR-CoV-2”

8 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 8 results

Not applicableStudy completedNCT04761874
What this trial is testing

Telestroke at Comprehensive Stroke Center During the COVID-19 Pandemic

Who this might be right for
Stroke, Acute
University of Minnesota 296
Not applicableStudy completedNCT05220514
What this trial is testing

Long-term Effects of COVID-19

Who this might be right for
COVID-19SAR-CoV-2
Mayo Clinic 71
Not applicableStudy completedNCT07049497
What this trial is testing

Study of Immune Response in Subjects Vaccinated Against SARS-CoV-2 Infection

Who this might be right for
SAR-CoV-2Cellular Immune ResponseAntibody Response
IRCCS San Raffaele 127
Not applicableEnded earlyNCT05044780
What this trial is testing

Hyperspectral Analysis of Sweat Metabolite Biometrics for Real-Time Detection of COVID-19

Who this might be right for
COVID-19
National Cancer Institute (NCI) 66
Post-approval studies (Phase 4)UnknownNCT04435587
What this trial is testing

Ivermectin vs Combined Hydroxychloroquine and Antiretroviral Drugs (ART) Among Asymptomatic COVID-19 Infection

Who this might be right for
Asymptomatic InfectionsSARS-CoV2 Infection
Mahidol University 80
Not applicableUnknownNCT04777981
What this trial is testing

(CBDRA60) to Prevent or Reduce Symptoms of COVID-19 and Prevention of Post-Acute Sequelae of SARS-CoV-2 Infection PASC

Who this might be right for
COVID-19SAR
Anewsha Therapeutics Inc. 60
Large-scale testing (Phase 3)Not Yet RecruitingNCT07314905
What this trial is testing

Adaptive Platform Trial of Treatments for Respiratory Infections in Community Settings (TreatResp)

Who this might be right for
Influenza AInfluenza BSAR-CoV-2+1 more
Unity Health Toronto 264
Testing effectiveness (Phase 2)Study completedNCT04710199
What this trial is testing

Trial to Evaluate the Safety and Efficacy of Maraviroc in Patients Hospitalized for Coronavirus Disease 2019 (COVID-19)

Who this might be right for
Virus Diseases
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 44